AU2001275707A1 - Use of panaxatriol for stimulation angiogenesis - Google Patents

Use of panaxatriol for stimulation angiogenesis

Info

Publication number
AU2001275707A1
AU2001275707A1 AU2001275707A AU7570701A AU2001275707A1 AU 2001275707 A1 AU2001275707 A1 AU 2001275707A1 AU 2001275707 A AU2001275707 A AU 2001275707A AU 7570701 A AU7570701 A AU 7570701A AU 2001275707 A1 AU2001275707 A1 AU 2001275707A1
Authority
AU
Australia
Prior art keywords
panaxatriol
stimulation angiogenesis
angiogenesis
stimulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275707A
Other languages
English (en)
Inventor
Tai-Ping Fan
Hi Wun Leung
Shiladitya Sengupta
Sue-Anne Ee Shiow Toh
Ngok Shun Ricky Wong
Yuk Ling Daisy Wong
Ying Kit Patrick Yue
Hin Wing Yueng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd CUTS
Hong Kong Baptist University HKBU
Original Assignee
Cambridge University Technical Services Ltd CUTS
Hong Kong Baptist University HKBU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018388A external-priority patent/GB0018388D0/en
Priority claimed from GBGB0105613.4A external-priority patent/GB0105613D0/en
Application filed by Cambridge University Technical Services Ltd CUTS, Hong Kong Baptist University HKBU filed Critical Cambridge University Technical Services Ltd CUTS
Publication of AU2001275707A1 publication Critical patent/AU2001275707A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001275707A 2000-07-26 2001-07-26 Use of panaxatriol for stimulation angiogenesis Abandoned AU2001275707A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0018388A GB0018388D0 (en) 2000-07-26 2000-07-26 Pharmaceutically effective compounds and their use
GB0018388.9 2000-07-26
GBGB0105613.4A GB0105613D0 (en) 2001-03-07 2001-03-07 Pharmaceutically effective compounds and their use
GB0105613.4 2001-03-07
PCT/GB2001/003360 WO2002007732A2 (fr) 2000-07-26 2001-07-26 Composes efficaces sur le plan pharmaceutique et utilisation associee

Publications (1)

Publication Number Publication Date
AU2001275707A1 true AU2001275707A1 (en) 2002-02-05

Family

ID=26244734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275707A Abandoned AU2001275707A1 (en) 2000-07-26 2001-07-26 Use of panaxatriol for stimulation angiogenesis

Country Status (2)

Country Link
AU (1) AU2001275707A1 (fr)
WO (1) WO2002007732A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10158281A1 (de) * 2001-11-19 2003-05-28 Mediwirk Gmbh Pharmazeutisches Präparat
DK1644009T3 (en) * 2003-06-23 2018-03-05 Telomerase Activation Sciences Inc Compositions for increasing telomerase activity and treating HIV infection
US9248088B2 (en) 2003-06-25 2016-02-02 Telomerase Activation Sciences, Inc. Compositions and methods for skin conditioning
CN100594910C (zh) * 2004-06-03 2010-03-24 昆明香格喜玛生物技术有限责任公司 具有生理活性的复方人参三醇皂苷及其制剂及用途
JP2008506686A (ja) * 2004-07-16 2008-03-06 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク ベータ−アミロイドペプチドの形成を阻害することによるアルツハイマー病治療用化合物及び製造
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
PL2437606T3 (pl) 2009-05-18 2017-07-31 Telomerase Activation Sciences, Inc. Kompozycje i sposoby zwiększania aktywności telomerazy
CN104644650A (zh) * 2013-11-18 2015-05-27 富力 20(R)-人参皂苷Rg3在制备改善和/或治疗脱发病症药物中的应用
CN104706697A (zh) * 2013-12-17 2015-06-17 兰州大学 人参在抑制ras原癌基因过表达中的应用
CN104706939A (zh) * 2013-12-17 2015-06-17 兰州大学 一种抑制ras原癌基因过表达的药物组合物
CN104706938A (zh) * 2013-12-17 2015-06-17 兰州大学 麦冬在抑制ras原癌基因过表达中的应用
CN104706937B (zh) * 2013-12-17 2018-12-21 兰州大学 生脉散在抑制ras原癌基因过表达中的应用
CN105267619B (zh) * 2014-06-07 2018-05-01 兰州大学 一种抑制ras原癌基因过表达的抗肿瘤中药复方提取物
US10679484B2 (en) 2017-02-01 2020-06-09 Fisher Controls International Llc Methods and apparatus for communicating alert notifications using discrete input channels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6038314A (ja) * 1983-08-10 1985-02-27 Osaka Chem Lab 育毛剤
FR2695561B1 (fr) * 1992-09-17 1994-12-02 Lvmh Rech Gie Composition cosmétique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux.
WO2000015792A2 (fr) * 1998-09-14 2000-03-23 Genentech, Inc. Promotion ou inhibition d'angiogenese et de cardiovascularisation
JPH1036388A (ja) * 1996-07-25 1998-02-10 Kureha Chem Ind Co Ltd ジンセノサイド類含有ｈｓｐ４７合成抑制剤
WO2001046455A2 (fr) * 1999-12-21 2001-06-28 Yale University Stimulation de l'angiogenèse par l'utilisation de survivine

Also Published As

Publication number Publication date
WO2002007732A2 (fr) 2002-01-31
WO2002007732A3 (fr) 2002-11-07

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001231223A1 (en) Therapeutic method for reducing angiogenesis
AU3947902A (en) Therapeutic agents and methods of use thereof for the modulation of angiogenesis
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2002222853A1 (en) Therapeutic compounds
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2001275707A1 (en) Use of panaxatriol for stimulation angiogenesis
AU2001233208A1 (en) Human sulfatases
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU2001293891A1 (en) New combination for the treatment of asthma
AU2001243515A1 (en) Combination drug therapy
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2001241771A1 (en) Use of avocado-soybean unsaponifiable preparations
AU2001273903A1 (en) Therapeutic agents
AU2001286341A1 (en) Therapeutic bio-energy unit
AU2001232335A1 (en) Skin preparations for external use
AU5646300A (en) Methods of stimulating angiogenesis
AU2001275696A1 (en) Therapeutic agent
AU6106801A (en) Trans-clitoral administration of therapy
AU2002215923A1 (en) Use of medicaments
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases